vs
Side-by-side financial comparison of Humacyte, Inc. (HUMA) and T Stamp Inc (IDAI). Click either name above to swap in a different company.
T Stamp Inc is the larger business by last-quarter revenue ($908.9K vs $467.0K, roughly 1.9× Humacyte, Inc.). T Stamp Inc produced more free cash flow last quarter ($2.0M vs $-26.2M).
Humacyte, Inc. is a clinical-stage biotechnology firm focused on developing and commercializing universally implantable off-the-shelf bioengineered human tissues and therapeutic products. Its core offerings target unmet needs in vascular care, trauma treatment and regenerative medicine, serving patients and healthcare partners worldwide.
T Stamp Inc, trading under ticker IDAI, develops AI-powered identity verification, trust scoring, and fraud prevention solutions. It serves clients across fintech, healthcare, and e-commerce segments, primarily operating in North America to help organizations securely authenticate user identities and mitigate fraud risks.
HUMA vs IDAI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $467.0K | $908.9K |
| Net Profit | — | $-2.5M |
| Gross Margin | -1844.8% | — |
| Operating Margin | -6603.0% | -224.9% |
| Net Margin | — | -279.9% |
| Revenue YoY | — | -39.3% |
| Net Profit YoY | — | 57.7% |
| EPS (diluted) | $-0.19 | $-0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $467.0K | $908.9K | ||
| Q3 25 | $753.0K | $872.5K | ||
| Q2 25 | $301.0K | $812.7K | ||
| Q1 25 | $517.0K | $545.5K | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | $0 | $511.1K | ||
| Q2 24 | $0 | $500.4K | ||
| Q1 24 | $0 | $573.7K |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-17.5M | $-1.9M | ||
| Q2 25 | $-37.7M | $-1.7M | ||
| Q1 25 | $39.1M | $-2.2M | ||
| Q4 24 | — | $-6.0M | ||
| Q3 24 | $-39.2M | $-1.3M | ||
| Q2 24 | $-56.7M | $-2.6M | ||
| Q1 24 | $-31.9M | $-2.7M |
| Q4 25 | -1844.8% | — | ||
| Q3 25 | 65.5% | — | ||
| Q2 25 | 29.2% | — | ||
| Q1 25 | 71.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -6603.0% | -224.9% | ||
| Q3 25 | -3239.0% | -203.0% | ||
| Q2 25 | -9876.1% | -207.0% | ||
| Q1 25 | -4484.3% | -396.5% | ||
| Q4 24 | — | -81.2% | ||
| Q3 24 | — | -523.7% | ||
| Q2 24 | — | -524.7% | ||
| Q1 24 | — | -496.7% |
| Q4 25 | — | -279.9% | ||
| Q3 25 | -2325.4% | -219.1% | ||
| Q2 25 | -12511.0% | -210.7% | ||
| Q1 25 | 7570.4% | -395.5% | ||
| Q4 24 | — | -401.5% | ||
| Q3 24 | — | -245.7% | ||
| Q2 24 | — | -519.3% | ||
| Q1 24 | — | -466.9% |
| Q4 25 | $-0.19 | $-0.37 | ||
| Q3 25 | $-0.11 | $-0.72 | ||
| Q2 25 | $-0.24 | $-0.69 | ||
| Q1 25 | $0.28 | $-0.89 | ||
| Q4 24 | — | $-3.14 | ||
| Q3 24 | $-0.33 | $-1.06 | ||
| Q2 24 | $-0.48 | $-3.19 | ||
| Q1 24 | $-0.29 | $-3.97 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $50.5M | $6.0M |
| Total DebtLower is stronger | $35.4M | — |
| Stockholders' EquityBook value | $3.1M | $8.7M |
| Total Assets | $116.4M | $11.2M |
| Debt / EquityLower = less leverage | 11.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $50.5M | $6.0M | ||
| Q3 25 | $19.5M | $5.4M | ||
| Q2 25 | $38.0M | $292.1K | ||
| Q1 25 | $62.8M | $1.1M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | $20.6M | $598.0K | ||
| Q2 24 | $93.6M | $659.5K | ||
| Q1 24 | $115.5M | $816.7K |
| Q4 25 | $35.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.1M | $8.7M | ||
| Q3 25 | $-4.8M | $6.1M | ||
| Q2 25 | $4.1M | $2.4M | ||
| Q1 25 | $36.0M | $4.1M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $-63.7M | $5.4M | ||
| Q2 24 | $-28.3M | $750.4K | ||
| Q1 24 | $26.2M | $1.4M |
| Q4 25 | $116.4M | $11.2M | ||
| Q3 25 | $91.5M | $11.2M | ||
| Q2 25 | $138.8M | $5.7M | ||
| Q1 25 | $162.6M | $6.6M | ||
| Q4 24 | — | $8.6M | ||
| Q3 24 | $114.8M | $10.6M | ||
| Q2 24 | $138.3M | $5.2M | ||
| Q1 24 | $161.5M | $5.6M |
| Q4 25 | 11.40× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-26.1M | $2.0M |
| Free Cash FlowOCF − Capex | $-26.2M | $2.0M |
| FCF MarginFCF / Revenue | -5602.4% | 215.4% |
| Capex IntensityCapex / Revenue | 8.4% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-105.9M | $-5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-26.1M | $2.0M | ||
| Q3 25 | $-23.9M | $-4.0M | ||
| Q2 25 | $-26.4M | $-2.1M | ||
| Q1 25 | $-28.6M | $-1.5M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $-22.9M | $-2.4M | ||
| Q2 24 | $-21.3M | $-1.6M | ||
| Q1 24 | $-27.3M | $-2.2M |
| Q4 25 | $-26.2M | $2.0M | ||
| Q3 25 | $-24.0M | $-4.0M | ||
| Q2 25 | $-27.0M | $-2.1M | ||
| Q1 25 | $-28.8M | $-1.6M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $-23.8M | $-2.4M | ||
| Q2 24 | $-21.5M | $-1.6M | ||
| Q1 24 | $-27.7M | $-2.2M |
| Q4 25 | -5602.4% | 215.4% | ||
| Q3 25 | -3181.0% | -459.6% | ||
| Q2 25 | -8963.8% | -258.6% | ||
| Q1 25 | -5576.2% | -289.2% | ||
| Q4 24 | — | -182.9% | ||
| Q3 24 | — | -475.4% | ||
| Q2 24 | — | -320.9% | ||
| Q1 24 | — | -376.6% |
| Q4 25 | 8.4% | 0.8% | ||
| Q3 25 | 6.5% | 0.0% | ||
| Q2 25 | 188.7% | 0.2% | ||
| Q1 25 | 44.1% | 6.8% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.73× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
